ID NADK2_SYNY3 Reviewed; 305 AA. AC P74430; DT 01-DEC-2000, integrated into UniProtKB/Swiss-Prot. DT 01-FEB-1997, sequence version 1. DT 27-MAR-2024, entry version 134. DE RecName: Full=NAD kinase 2 {ECO:0000255|HAMAP-Rule:MF_00361}; DE EC=2.7.1.23 {ECO:0000255|HAMAP-Rule:MF_00361, ECO:0000305|PubMed:22056937, ECO:0000305|PubMed:27657983, ECO:0000305|PubMed:33560438}; DE AltName: Full=ATP-dependent NAD kinase 2 {ECO:0000255|HAMAP-Rule:MF_00361}; GN Name=nadK2 {ECO:0000255|HAMAP-Rule:MF_00361}; GN OrderedLocusNames=slr0400; OS Synechocystis sp. (strain PCC 6803 / Kazusa). OC Bacteria; Cyanobacteriota; Cyanophyceae; Synechococcales; Merismopediaceae; OC Synechocystis. OX NCBI_TaxID=1111708; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=PCC 6803 / Kazusa; RX PubMed=8905231; DOI=10.1093/dnares/3.3.109; RA Kaneko T., Sato S., Kotani H., Tanaka A., Asamizu E., Nakamura Y., RA Miyajima N., Hirosawa M., Sugiura M., Sasamoto S., Kimura T., Hosouchi T., RA Matsuno A., Muraki A., Nakazaki N., Naruo K., Okumura S., Shimpo S., RA Takeuchi C., Wada T., Watanabe A., Yamada M., Yasuda M., Tabata S.; RT "Sequence analysis of the genome of the unicellular cyanobacterium RT Synechocystis sp. strain PCC6803. II. Sequence determination of the entire RT genome and assignment of potential protein-coding regions."; RL DNA Res. 3:109-136(1996). RN [2] RP FUNCTION, AND DISRUPTION PHENOTYPE. RC STRAIN=PCC 6803 / Kazusa; RX PubMed=22056937; DOI=10.1128/jb.05873-11; RA Gao H., Xu X.; RT "The cyanobacterial NAD kinase gene sll1415 is required for RT photoheterotrophic growth and cellular redox homeostasis in Synechocystis RT sp. strain PCC 6803."; RL J. Bacteriol. 194:218-224(2012). RN [3] RP DISRUPTION PHENOTYPE. RC STRAIN=PCC 6803 / Kazusa; RX PubMed=27657983; DOI=10.1016/j.jplph.2016.09.002; RA Ishikawa Y., Miyagi A., Haishima Y., Ishikawa T., Nagano M., Yamaguchi M., RA Hihara Y., Kawai-Yamada M.; RT "Metabolomic analysis of NAD kinase-deficient mutants of the cyanobacterium RT Synechocystis sp. PCC 6803."; RL J. Plant Physiol. 205:105-112(2016). RN [4] RP FUNCTION, INDUCTION, AND DISRUPTION PHENOTYPE. RC STRAIN=PCC 6803 / Kazusa; RX PubMed=30693583; DOI=10.1111/tpj.14262; RA Ishikawa Y., Miyagi A., Ishikawa T., Nagano M., Yamaguchi M., Hihara Y., RA Kaneko Y., Kawai-Yamada M.; RT "One of the NAD kinases, sll1415, is required for the glucose metabolism of RT Synechocystis sp. PCC 6803."; RL Plant J. 98:654-666(2019). RN [5] RP FUNCTION, AND DISRUPTION PHENOTYPE. RC STRAIN=PCC 6803 / Kazusa; RX PubMed=33560438; DOI=10.1093/pcp/pcab023; RA Ishikawa Y., Cassan C., Kadeer A., Yuasa K., Sato N., Sonoike K., RA Kaneko Y., Miyagi A., Takahashi H., Ishikawa T., Yamaguchi M., RA Nishiyama Y., Hihara Y., Gibon Y., Kawai-Yamada M.; RT "The NAD kinase Slr0400 functions as a growth repressor in Synechocystis RT sp. PCC 6803."; RL Plant Cell Physiol. 62:668-677(2021). CC -!- FUNCTION: Involved in the regulation of the intracellular balance of CC NAD and NADP, and is a key enzyme in the biosynthesis of NADP. CC Catalyzes specifically the phosphorylation on 2'-hydroxyl of the CC adenosine moiety of NAD to yield NADP (PubMed:22056937, CC PubMed:30693583). Functions as a growth repressor under light-activated CC heterotrophic growth conditions and light and dark cycle conditions in CC the presence of glucose (PubMed:33560438). NADP(H)/NAD(H) maintenance CC by slr0400 probably plays a significant role in modulating glycolysis CC and the TCA cycle to repress the growth rate and maintain the CC photosynthetic capacity (PubMed:33560438). CC {ECO:0000269|PubMed:22056937, ECO:0000269|PubMed:30693583, CC ECO:0000269|PubMed:33560438}. CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + NAD(+) = ADP + H(+) + NADP(+); Xref=Rhea:RHEA:18629, CC ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:57540, CC ChEBI:CHEBI:58349, ChEBI:CHEBI:456216; EC=2.7.1.23; CC Evidence={ECO:0000255|HAMAP-Rule:MF_00361, CC ECO:0000305|PubMed:22056937, ECO:0000305|PubMed:27657983, CC ECO:0000305|PubMed:33560438}; CC -!- COFACTOR: CC Name=a divalent metal cation; Xref=ChEBI:CHEBI:60240; CC Evidence={ECO:0000255|HAMAP-Rule:MF_00361}; CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_00361}. CC -!- INDUCTION: Expression decreases after transfer to photoheterotrophic CC conditions. {ECO:0000269|PubMed:30693583}. CC -!- DISRUPTION PHENOTYPE: Insertion mutant shows a slight decrease in NADK CC activity compared to the wild-type (PubMed:22056937, PubMed:27657983). CC Under photoheterotrophic conditions, mutation does not affect growth CC rate (PubMed:22056937, PubMed:30693583). Under photoautotrophic CC conditions, the growth curves of the wild-type parent and the mutant do CC not show any differences, but mutant shows large differences in CC NAD(P)(H) levels along with massive changes in metabolite profile CC (PubMed:27657983). Mutant exhibits a fast-growth phenotype under light- CC activated heterotrophic growth conditions and light and dark cycle CC conditions in the presence of glucose (PubMed:33560438). CC {ECO:0000269|PubMed:22056937, ECO:0000269|PubMed:27657983, CC ECO:0000269|PubMed:30693583, ECO:0000269|PubMed:33560438}. CC -!- MISCELLANEOUS: NADK activity derived from sll1415 makes probably a CC larger contribution to total cellular NADK activity than activity CC derived from slr0400 (PubMed:22056937, PubMed:27657983). Slr0400 cannot CC functionally replace sll1415 under photoheterotrophic conditions CC (PubMed:30693583). {ECO:0000269|PubMed:22056937, CC ECO:0000269|PubMed:27657983, ECO:0000269|PubMed:30693583}. CC -!- SIMILARITY: Belongs to the NAD kinase family. {ECO:0000255|HAMAP- CC Rule:MF_00361}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; BA000022; BAA18530.1; -; Genomic_DNA. DR PIR; S76401; S76401. DR AlphaFoldDB; P74430; -. DR SMR; P74430; -. DR STRING; 1148.gene:10499411; -. DR PaxDb; 1148-1653618; -. DR EnsemblBacteria; BAA18530; BAA18530; BAA18530. DR KEGG; syn:slr0400; -. DR eggNOG; COG0061; Bacteria. DR InParanoid; P74430; -. DR PhylomeDB; P74430; -. DR BRENDA; 2.7.1.23; 382. DR Proteomes; UP000001425; Chromosome. DR GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell. DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-UniRule. DR GO; GO:0051287; F:NAD binding; IEA:UniProt. DR GO; GO:0003951; F:NAD+ kinase activity; IBA:GO_Central. DR GO; GO:0019674; P:NAD metabolic process; IEA:InterPro. DR GO; GO:0006741; P:NADP biosynthetic process; IBA:GO_Central. DR GO; GO:0016310; P:phosphorylation; IEA:UniProtKB-KW. DR HAMAP; MF_00361; NAD_kinase; 1. DR InterPro; IPR017438; ATP-NAD_kinase_N. DR InterPro; IPR017437; ATP-NAD_kinase_PpnK-typ_C. DR InterPro; IPR016064; NAD/diacylglycerol_kinase_sf. DR InterPro; IPR002504; NADK. DR PANTHER; PTHR20275; NAD KINASE; 1. DR PANTHER; PTHR20275:SF13; NAD KINASE 1; 1. DR Pfam; PF01513; NAD_kinase; 1. DR Pfam; PF20143; NAD_kinase_C; 1. DR SUPFAM; SSF111331; NAD kinase/diacylglycerol kinase-like; 1. PE 2: Evidence at transcript level; KW ATP-binding; Cytoplasm; Kinase; NAD; NADP; Nucleotide-binding; KW Reference proteome; Transferase. FT CHAIN 1..305 FT /note="NAD kinase 2" FT /id="PRO_0000120678" FT ACT_SITE 78 FT /note="Proton acceptor" FT /evidence="ECO:0000255|HAMAP-Rule:MF_00361" FT BINDING 78..79 FT /ligand="NAD(+)" FT /ligand_id="ChEBI:CHEBI:57540" FT /evidence="ECO:0000255|HAMAP-Rule:MF_00361" FT BINDING 152..153 FT /ligand="NAD(+)" FT /ligand_id="ChEBI:CHEBI:57540" FT /evidence="ECO:0000255|HAMAP-Rule:MF_00361" FT BINDING 182 FT /ligand="NAD(+)" FT /ligand_id="ChEBI:CHEBI:57540" FT /evidence="ECO:0000255|HAMAP-Rule:MF_00361" FT BINDING 193..198 FT /ligand="NAD(+)" FT /ligand_id="ChEBI:CHEBI:57540" FT /evidence="ECO:0000255|HAMAP-Rule:MF_00361" FT BINDING 251 FT /ligand="NAD(+)" FT /ligand_id="ChEBI:CHEBI:57540" FT /evidence="ECO:0000255|HAMAP-Rule:MF_00361" SQ SEQUENCE 305 AA; 33398 MW; 695ED7EA16244E2C CRC64; MPKVGIIFND DKPTACSVAQ ELQEQLQQSG FTVAMETGSG GLLGYSQPDR PICHTRIEHL TPPHFDESMP FAIVLGGDGT VLSAFRQLAP LGIPLLTINT GHMGFLTEIY LNQLPTAIEQ LINGDYQIES RSMMTVRLMR EENLLWEALS LNEMVLHREP LTSMCHFEIQ VGYHASVDIA ADGIIVSTPT GSTAYSLSAG GPVVTPDVPV FQLAPICPHS LASRALVFSD LEPVTIFPAT PNRMVLVVDG NGGCYVLPED RVHLSKSPYP AKFIRLQTPE FFRILREKLG WGLPHIAKPT SVELP //